| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/10/2001 | WO2001032888A2 Human transferase molecules |
| 05/10/2001 | WO2001032882A2 Nucleic acids and proteins from group b streptococcus |
| 05/10/2001 | WO2001032878A2 A novel polypeptide hormone phosphatonin |
| 05/10/2001 | WO2001032877A2 CpG RECEPTOR (CpG-R) AND METHODS RELATING THERETO |
| 05/10/2001 | WO2001032865A1 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 05/10/2001 | WO2001032864A2 Gpcr-kd5 polypeptides and dna sequences thereof |
| 05/10/2001 | WO2001032861A1 Tumour suppressor genes from chromosome 16 |
| 05/10/2001 | WO2001032837A1 19 human secreted proteins |
| 05/10/2001 | WO2001032714A1 Recombinant fusion molecules |
| 05/10/2001 | WO2001032713A1 Production of mammary secretion antibodies in farm animals |
| 05/10/2001 | WO2001032712A2 Antibody diversity generation |
| 05/10/2001 | WO2001032708A1 Compounds, antibodies and methods for treating, preventing or diagnosing tumour metastasis |
| 05/10/2001 | WO2001032705A1 Ghsr ligand polypeptides and dnas thereof |
| 05/10/2001 | WO2001032704A1 Choline transporter like (ctl) membrane proteins involved in choline transport |
| 05/10/2001 | WO2001032702A2 Molecular structure of rhd negative locus |
| 05/10/2001 | WO2001032696A2 Traf family proteins |
| 05/10/2001 | WO2001032695A2 MODULATION OF eNOS ACTIVITY AND THERAPEUTIC USES THEREOF |
| 05/10/2001 | WO2001032687A1 10 human secreted proteins |
| 05/10/2001 | WO2001032677A1 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 05/10/2001 | WO2001032676A1 25 human secreted proteins |
| 05/10/2001 | WO2001032675A1 32 human secreted proteins |
| 05/10/2001 | WO2001032674A1 26 human secreted proteins |
| 05/10/2001 | WO2001032673A1 Sequences encoding human neoplastic marker |
| 05/10/2001 | WO2001032614A2 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 05/10/2001 | WO2001032209A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 05/10/2001 | WO2001032128A2 Human chemokine beta-13 |
| 05/10/2001 | WO2001032070A2 Reagents and methods for diagnosing, imaging and treating atherosclerotic disease |
| 05/10/2001 | WO2001021804B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/10/2001 | WO2001010459A3 Fish vaccine |
| 05/10/2001 | WO2001007480A3 Use of interleukin-18 inhibitors to inhibit tumor metastasis |
| 05/10/2001 | WO2000077207A3 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto |
| 05/10/2001 | WO2000077035A3 Novel potassium channels and genes encoding these potassium channels |
| 05/10/2001 | WO2000075191A3 Apo-2L RECEPTOR AGONIST AND CPT-11 SYNERGISM |
| 05/10/2001 | WO2000064488A3 Somatic transgene immunization and related methods |
| 05/10/2001 | WO2000063435A8 Method of identifying toxic agents using differential gene expression |
| 05/10/2001 | WO2000063241A3 Methods and compositions for modulating an immune response |
| 05/10/2001 | WO2000061635A3 Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-egp-2 scfv fragment |
| 05/10/2001 | WO2000061067B1 Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein |
| 05/10/2001 | WO2000034334A9 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF |
| 05/10/2001 | US20010001061 Assay for disease related conformation of a protein |
| 05/10/2001 | DE19952960A1 Verfahren zur Identifizierung von anti-apoptotisch wirksamen Verbindungen A method of identifying anti-apoptotically active compounds |
| 05/10/2001 | CA2390180A1 Choline transporter like (ctl) membrane proteins involved in choline transport |
| 05/10/2001 | CA2389964A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 05/10/2001 | CA2389849A1 Reagents and methods for diagnosing, imaging and treating atherosclerotic disease |
| 05/10/2001 | CA2389765A1 Cpg receptor (cpg-r) and methods relating thereto |
| 05/10/2001 | CA2389751A1 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same |
| 05/10/2001 | CA2389672A1 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 05/10/2001 | CA2389644A1 A novel polypeptide hormone phosphatonin |
| 05/10/2001 | CA2389574A1 Ghsr ligand polypeptides and dnas thereof |
| 05/10/2001 | CA2389415A1 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 05/10/2001 | CA2389339A1 Recombinant therapeutic fusion proteins |
| 05/10/2001 | CA2388955A1 Recombinant fusion molecules |
| 05/10/2001 | CA2388822A1 27 human secreted proteins |
| 05/10/2001 | CA2388612A1 Sequences encoding human neoplastic marker |
| 05/10/2001 | CA2388511A1 Tissue specific genes of diagnostic import |
| 05/10/2001 | CA2388308A1 Gpcr-kd5 polypeptides and dna sequences thereof |
| 05/10/2001 | CA2387808A1 Human chemokine beta-13 |
| 05/10/2001 | CA2387801A1 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 05/10/2001 | CA2387799A1 19 human secreted proteins |
| 05/10/2001 | CA2387785A1 Human transferase molecules |
| 05/10/2001 | CA2387754A1 10 human secreted proteins |
| 05/10/2001 | CA2387261A1 25 human secreted proteins |
| 05/10/2001 | CA2387136A1 26 human secreted proteins |
| 05/10/2001 | CA2386641A1 32 human secreted proteins |
| 05/10/2001 | CA2385665A1 Modulation of enos activity and therapeutic uses thereof |
| 05/10/2001 | CA2382455A1 Nucleic acids and proteins from group b streptococcus |
| 05/09/2001 | EP1098198A1 Method for the qualitative and quantitative determination of class igG human antibodies |
| 05/09/2001 | EP1097991A2 Human adenylate cyclase IX and use therefor |
| 05/09/2001 | EP1097989A2 Ndr phosphokinase |
| 05/09/2001 | EP1097945A2 Monoclonal and chimeric antibody specific for human tumor necrosis factor |
| 05/09/2001 | EP1097944A1 Antibody against protein tyrosine phosphatase intracellular domains |
| 05/09/2001 | EP1097942A2 Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes |
| 05/09/2001 | EP1097241A1 Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe |
| 05/09/2001 | EP1097226A1 Usurpin, a mammalian ded-caspase homologue that precludes caspase-8 recruitment and activation by the cd-95 (fas, apo-1) receptor complex |
| 05/09/2001 | EP1097219A2 Human scad-related molecules, scrm-1 and scrm-2 |
| 05/09/2001 | EP1097210A1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 05/09/2001 | EP1097208A2 Compositions and methods for therapy and diagnosis of prostate cancer |
| 05/09/2001 | EP1097206A1 Human calcium regulatory proteins |
| 05/09/2001 | EP1097203A1 Human presenilin-associated protein |
| 05/09/2001 | EP1097202A2 Human transport protein homologs |
| 05/09/2001 | EP1097201A1 Snurpotine i human m 3?g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
| 05/09/2001 | EP1097199A1 71 human secreted proteins |
| 05/09/2001 | EP1097198A2 Soluble derivatives of anti-angiogenic peptides |
| 05/09/2001 | EP1097174A1 Lupus anticoagulant antibody to f1 region of prothrombin |
| 05/09/2001 | EP1097173A1 Peptides of il-2 and derivatives thereof and their use as therapeutic agents |
| 05/09/2001 | EP1097172A1 Anti hepatitis c virus antibody and uses thereof |
| 05/09/2001 | EP1097168A2 Compounds and methods for modulating cadherin-mediated functions |
| 05/09/2001 | EP1097167A2 Neurotrophic growth factor |
| 05/09/2001 | EP1097166A2 Potassium channel polypeptide and polynucleotide compositions |
| 05/09/2001 | EP1097165A1 Novel inhibitors of angiogenesis and tumor growth |
| 05/09/2001 | EP1096955A2 Cancer treatment methods using antibodies to aminophospholipids |
| 05/09/2001 | EP1096953A1 Use of inactivated immunosuppressive and/or angiogenic immunogenic proteins, preparation method and pharmaceutical or vaccine uses |
| 05/09/2001 | EP1096949A2 Treatment of celiac disease with interleukin-15 antagonists |
| 05/09/2001 | EP1096946A2 Delta cleavage products and methods based thereon |
| 05/09/2001 | EP0514411B1 Polypeptides and dna encoding same, associated with human malaria parasites |
| 05/09/2001 | CN1294632A Compsns. derived from i(mycobacterium vaccae) and methods for their use |
| 05/09/2001 | CN1294598A Epitopes in viral envelope proteins and specific antibodies directed against these eptitopes: use for detection of HCV viral antigen in host tissue |
| 05/09/2001 | CN1294596A Method for reducing immunogenicity of proteins |
| 05/09/2001 | CN1294517A Immunoglobulin molecules having synthetic variable region and modified specificity |
| 05/09/2001 | CN1294192A Processf or preparing abzyme with activity of thyroxin 5' deiodinase |